Sept 17-19, 2019
Parsippany, New Jersey Hilton Hotel

> 2018 Exhibitors

> 2017 Exhibitors

> 2016 Exhibitors

Download 2019 Exhibitor Manual

Download Exhibitor Electric Form

ChemOutsourcing Banner To Alert Contacts You’re Attending

2019 Exhibitor List

read: buyers and suppliers together

Exhibitor List As Of September 15, 2019

Look for exhibitors according to their first letter.

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Show All

 

PMC Isochem
Procos SpA

PMC Isochem, Booth 93 [ company website ]

PMC Isochem offers contract research, custom manufacturing and catalogue products for Pharmaceutical companies worldwide. Our offer addresses three areas:

  • CDMO services: GMP industrial exclusive custom synthesis and provides tailor made services from development to production, including route selection. 3 FDA audited manufacturing plants
  • Drug delivery solutions: TPGS-1000 NF USP for poorly soluble drug formulation and Polypeptides based solution for Nano Encapsulation and Polymer Drug Conjugates
  • Generic APIs: 20 generic API  for US, EU and worldwide market

Procos SpA, Booth 68 [ company website ]

Procos S.p.A., established in 1945, is a wholly owned subsidiary of the Japanese company, CBC Co. Ltd. Group, specializing in the development, scale-up and production of Active Pharmaceutical Ingredients (API’s), High Potency Active Pharmaceutical Ingredients (HPAPI’s) for oncology, advanced intermediates and related services for the pharmaceutical industry.

Our core business sectors include custom synthesis and Generic API manufacturing. The manufacturing site is located in Cameri, Italy. The 110,000 square meter, cutting-edge multipurpose plant, fully designed under cGMP compliance, has been successfully audited and approved by the main regulatory authorities including AIFA, FDA and PMDA. To ensure our constant growth in an increasingly competitive market, Procos strives to pursue new innovation, while keeping our core identity, by constantly investing in our company and in our people.